Fast-Track Moderna’s HSV-2 Vaccine & Fund HSV Cure Research at Fred Hutch


Fast-Track Moderna’s HSV-2 Vaccine & Fund HSV Cure Research at Fred Hutch
The Issue
Herpes simplex virus type 2 (HSV-2) affects an estimated 500 million people globally, causing painful genital outbreaks, stigma, and a heightened risk of HIV transmission. Despite the massive public health burden, there is still no approved vaccine or cure for genital herpes.
What’s New: A Promising HSV-2 Vaccine from Moderna
Moderna’s investigational mRNA-1608 vaccine is showing unprecedented promise:
- 100% protection against lethal HSV-2 challenge in animal models
- No detectable latent virus in sensory neurons post-vaccination
- Dramatic reduction in viral shedding and transmission potential
- Strong safety and immune response in ongoing human trials (Phase 1/2)
This could be the first true HSV vaccine—but only if it gets the attention, funding, and fast-tracking it needs.
Fred Hutch’s Role in the Cure, Meanwhile, Fred Hutchinson Cancer Center and other top U.S. research institutions are leading foundational studies into:
- Herpes latency and immune escape
- Therapeutic vaccine strategies
- mRNA platforms and viral immunology
What We’re Demanding:
- Fast-track FDA review of Moderna’s mRNA-1608 vaccine
- Authorize Emergency Use pathways if human safety and immune data support it
- Substantially increase federal research funding (via NIH, BARDA, etc.) for HSV vaccines, cures, and latency reversal
- Create donation-friendly channels to fund labs like Fred Hutch and HSV-focused biotech companies
- Coordinate public-private partnerships to accelerate Phase 3 trials, manufacturing, and global access
Why This Matters:
- HSV-2 causes lifelong pain, stigma, and emotional trauma
- A vaccine or cure could prevent millions of new infections and reduce HIV risk
- HSV research is underfunded and overlooked, despite the scale of suffering
- We have the technology and momentum—we just need leadership and investment
Join Us
Help us reach 100,000 signatures so that the FDA, NIH, Congress, and the White House hear our call:
- Support HSV-2 vaccine development and fund a cure.
Let’s end the silence around herpes. Let’s demand action. Let’s fight for health, dignity, and hope.
91
The Issue
Herpes simplex virus type 2 (HSV-2) affects an estimated 500 million people globally, causing painful genital outbreaks, stigma, and a heightened risk of HIV transmission. Despite the massive public health burden, there is still no approved vaccine or cure for genital herpes.
What’s New: A Promising HSV-2 Vaccine from Moderna
Moderna’s investigational mRNA-1608 vaccine is showing unprecedented promise:
- 100% protection against lethal HSV-2 challenge in animal models
- No detectable latent virus in sensory neurons post-vaccination
- Dramatic reduction in viral shedding and transmission potential
- Strong safety and immune response in ongoing human trials (Phase 1/2)
This could be the first true HSV vaccine—but only if it gets the attention, funding, and fast-tracking it needs.
Fred Hutch’s Role in the Cure, Meanwhile, Fred Hutchinson Cancer Center and other top U.S. research institutions are leading foundational studies into:
- Herpes latency and immune escape
- Therapeutic vaccine strategies
- mRNA platforms and viral immunology
What We’re Demanding:
- Fast-track FDA review of Moderna’s mRNA-1608 vaccine
- Authorize Emergency Use pathways if human safety and immune data support it
- Substantially increase federal research funding (via NIH, BARDA, etc.) for HSV vaccines, cures, and latency reversal
- Create donation-friendly channels to fund labs like Fred Hutch and HSV-focused biotech companies
- Coordinate public-private partnerships to accelerate Phase 3 trials, manufacturing, and global access
Why This Matters:
- HSV-2 causes lifelong pain, stigma, and emotional trauma
- A vaccine or cure could prevent millions of new infections and reduce HIV risk
- HSV research is underfunded and overlooked, despite the scale of suffering
- We have the technology and momentum—we just need leadership and investment
Join Us
Help us reach 100,000 signatures so that the FDA, NIH, Congress, and the White House hear our call:
- Support HSV-2 vaccine development and fund a cure.
Let’s end the silence around herpes. Let’s demand action. Let’s fight for health, dignity, and hope.
91
The Decision Makers



Supporter Voices
Petition created on May 19, 2025
